Cargando…

Early antitumor activity of oral Langerhans cells is compromised by a carcinogen

Early diagnosis of oral squamous cell carcinoma (OSCC) remains an unmet clinical need. Therefore, elucidating the initial events of OSCC preceding tumor development could benefit OSCC prognosis. Here, we define the Langerhans cells (LCs) of the tongue and demonstrate that LCs protect the epithelium...

Descripción completa

Detalles Bibliográficos
Autores principales: Saba, Yasmin, Aizenbud, Itay, Matanes, Daniela, Koren, Noam, Barel, Or, Zubeidat, Khalid, Capucha, Tal, David, Eyal, Eli-Berchoer, Luba, Stoitzner, Patrizia, Wilensky, Asaf, Amit, Ido, Czerninski, Rakefet, Yona, Simon, Hovav, Avi-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784117/
https://www.ncbi.nlm.nih.gov/pubmed/35012988
http://dx.doi.org/10.1073/pnas.2118424119
_version_ 1784638664160051200
author Saba, Yasmin
Aizenbud, Itay
Matanes, Daniela
Koren, Noam
Barel, Or
Zubeidat, Khalid
Capucha, Tal
David, Eyal
Eli-Berchoer, Luba
Stoitzner, Patrizia
Wilensky, Asaf
Amit, Ido
Czerninski, Rakefet
Yona, Simon
Hovav, Avi-Hai
author_facet Saba, Yasmin
Aizenbud, Itay
Matanes, Daniela
Koren, Noam
Barel, Or
Zubeidat, Khalid
Capucha, Tal
David, Eyal
Eli-Berchoer, Luba
Stoitzner, Patrizia
Wilensky, Asaf
Amit, Ido
Czerninski, Rakefet
Yona, Simon
Hovav, Avi-Hai
author_sort Saba, Yasmin
collection PubMed
description Early diagnosis of oral squamous cell carcinoma (OSCC) remains an unmet clinical need. Therefore, elucidating the initial events of OSCC preceding tumor development could benefit OSCC prognosis. Here, we define the Langerhans cells (LCs) of the tongue and demonstrate that LCs protect the epithelium from carcinogen-induced OSCC by rapidly priming αβT cells capable of eliminating γH2AX(+) epithelial cells, whereas γδT and natural killer cells are dispensable. The carcinogen, however, dysregulates the epithelial resident mononuclear phagocytes, reducing LC frequencies, while dendritic cells (DCs), macrophages, and plasmacytoid DCs (pDCs) populate the epithelium. Single-cell RNA-sequencing analysis indicates that these newly differentiated cells display an immunosuppressive phenotype accompanied by an expansion of T regulatory (Treg) cells. Accumulation of the Treg cells was regulated, in part, by pDCs and precedes the formation of visible tumors. This suggests LCs play an early protective role during OSCC, yet the capacity of the carcinogen to dysregulate the differentiation of mononuclear phagocytes facilitates oral carcinogenesis.
format Online
Article
Text
id pubmed-8784117
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-87841172022-07-10 Early antitumor activity of oral Langerhans cells is compromised by a carcinogen Saba, Yasmin Aizenbud, Itay Matanes, Daniela Koren, Noam Barel, Or Zubeidat, Khalid Capucha, Tal David, Eyal Eli-Berchoer, Luba Stoitzner, Patrizia Wilensky, Asaf Amit, Ido Czerninski, Rakefet Yona, Simon Hovav, Avi-Hai Proc Natl Acad Sci U S A Biological Sciences Early diagnosis of oral squamous cell carcinoma (OSCC) remains an unmet clinical need. Therefore, elucidating the initial events of OSCC preceding tumor development could benefit OSCC prognosis. Here, we define the Langerhans cells (LCs) of the tongue and demonstrate that LCs protect the epithelium from carcinogen-induced OSCC by rapidly priming αβT cells capable of eliminating γH2AX(+) epithelial cells, whereas γδT and natural killer cells are dispensable. The carcinogen, however, dysregulates the epithelial resident mononuclear phagocytes, reducing LC frequencies, while dendritic cells (DCs), macrophages, and plasmacytoid DCs (pDCs) populate the epithelium. Single-cell RNA-sequencing analysis indicates that these newly differentiated cells display an immunosuppressive phenotype accompanied by an expansion of T regulatory (Treg) cells. Accumulation of the Treg cells was regulated, in part, by pDCs and precedes the formation of visible tumors. This suggests LCs play an early protective role during OSCC, yet the capacity of the carcinogen to dysregulate the differentiation of mononuclear phagocytes facilitates oral carcinogenesis. National Academy of Sciences 2022-01-10 2022-01-18 /pmc/articles/PMC8784117/ /pubmed/35012988 http://dx.doi.org/10.1073/pnas.2118424119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Biological Sciences
Saba, Yasmin
Aizenbud, Itay
Matanes, Daniela
Koren, Noam
Barel, Or
Zubeidat, Khalid
Capucha, Tal
David, Eyal
Eli-Berchoer, Luba
Stoitzner, Patrizia
Wilensky, Asaf
Amit, Ido
Czerninski, Rakefet
Yona, Simon
Hovav, Avi-Hai
Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
title Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
title_full Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
title_fullStr Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
title_full_unstemmed Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
title_short Early antitumor activity of oral Langerhans cells is compromised by a carcinogen
title_sort early antitumor activity of oral langerhans cells is compromised by a carcinogen
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784117/
https://www.ncbi.nlm.nih.gov/pubmed/35012988
http://dx.doi.org/10.1073/pnas.2118424119
work_keys_str_mv AT sabayasmin earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT aizenbuditay earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT matanesdaniela earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT korennoam earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT barelor earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT zubeidatkhalid earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT capuchatal earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT davideyal earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT eliberchoerluba earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT stoitznerpatrizia earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT wilenskyasaf earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT amitido earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT czerninskirakefet earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT yonasimon earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen
AT hovavavihai earlyantitumoractivityoforallangerhanscellsiscompromisedbyacarcinogen